Your blood sugar report may fall within the normal range, but that does not always tell the complete story of your metabolic health. Insulin resistance can develop before blood glucose levels become high enough to meet the criteria for prediabetes or Recognising the risk factors early can help you and your doctor decide whether further assessment is needed. However, diabetes risk involves more than blood sugar alone. Insulin, body fat and cholesterol levels also play important roles in metabolic health.
Insulin resistance can develop without obvious symptoms. Therefore, understanding the associated risk factors and choosing the right tests can help you assess your metabolic health more effectively.
Insulin is a hormone produced by the pancreas. It helps glucose move from the bloodstream into cells, where the body uses it for energy.
When cells respond less effectively to insulin, doctors call this condition insulin resistance. Initially, the pancreas may produce more insulin to keep blood glucose within a healthy range. However, this response may become insufficient over time, causing blood sugar levels to rise.
In addition, insulin resistance is associated with abdominal obesity, abnormal triglycerides, high blood pressure and an increased risk of type 2 diabetes.
The Indian Council of Medical Research (ICMR) highlights insulin resistance as an important feature of type 2 diabetes. Abdominal and visceral fat also play an important role in metabolic health, particularly among Indian populations.
Insulin resistance often develops without obvious symptoms. Therefore, doctors cannot reliably identify it through symptoms alone. However, certain physical findings and metabolic risk factors may indicate that further assessment is appropriate.
A larger waist circumference can indicate excess visceral fat, which is stored around internal organs. This type of fat is linked to insulin resistance and other metabolic risk factors.
For this reason, waist circumference can be a useful part of a broader health assessment. However, it cannot confirm insulin resistance on its own.
A condition called acanthosis nigricans can cause darker, thicker or velvety-looking skin, particularly around the neck, armpits or other skin folds.
This skin change may be associated with insulin resistance. Nevertheless, other conditions can also cause similar changes, so a clinician should assess new or changing skin findings.
A lipid profile showing high triglycerides or low HDL cholesterol may indicate an unfavourable metabolic pattern. These changes become more relevant when they occur alongside abdominal obesity, high blood pressure or abnormal blood sugar.
Therefore, doctors may consider cholesterol and triglyceride levels when assessing a person’s overall metabolic risk.
Having a close relative with type 2 diabetes can increase your risk. In addition, physical inactivity, excess abdominal fat and high blood pressure may further increase the need for a metabolic health assessment.
However, family history alone does not mean that you have insulin resistance or will develop diabetes.
These signs and risk factors do not confirm insulin resistance. Instead, they help your doctor decide whether further assessment is appropriate.
No single routine blood test definitively diagnoses insulin resistance in every person. Different tests provide different information, so your doctor can select the most appropriate options based on your medical history, examination and risk factors.
Fasting blood glucose measures blood sugar after an overnight fast. Doctors commonly use this test to identify elevated fasting glucose and assess diabetes risk.
A normal result is reassuring about your fasting glucose level at that time. However, it does not rule out insulin resistance on its own.
The HbA1c test estimates your average blood glucose over approximately the previous two to three months. It helps doctors assess whether blood sugar levels fall within the normal, prediabetes or diabetes range.
However, HbA1c measures longer-term blood glucose, not the body’s direct response to insulin. As a result, some people may have insulin resistance before their HbA1c becomes abnormal.
Certain conditions can also affect HbA1c accuracy, so your doctor may consider additional tests when necessary.
Fasting insulin measures the amount of insulin in your blood after fasting. In addition, doctors can use fasting insulin and fasting glucose together to calculate the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR).
HOMA-IR provides an indirect estimate of insulin resistance and may be useful in selected clinical and research settings.
However, its interpretation depends on factors such as the insulin test method, the person’s health and the reference population. There is no universally accepted cutoff that diagnoses insulin resistance in every Indian adult.
Therefore, doctors do not need to order fasting insulin or HOMA-IR for everyone undergoing routine diabetes screening. They may consider these tests when additional information would help with a specific clinical assessment.
A lipid profile measures cholesterol and triglycerides in the blood. High triglycerides and low HDL cholesterol can provide useful clues about metabolic health, particularly when combined with other risk factors.
Doctors interpret these results alongside blood glucose, blood pressure, waist circumference and medical history. A lipid profile alone cannot confirm insulin resistance.
An Oral Glucose Tolerance Test evaluates how your body handles a measured glucose drink. The healthcare team measures blood glucose at specified times, usually before and two hours after the drink.
Doctors may recommend this test when they need more information about glucose regulation. It is an established test for assessing glucose tolerance, although it does not directly measure insulin resistance.
A discussion with your doctor may be particularly useful if you have one or more of the following risk factors:
ICMR guidance recommends diabetes screening from age 30 in the general population, with earlier assessment when relevant risk factors warrant it. Your doctor can advise you on the right screening schedule based on your individual circumstances.
Remember, having one or more risk factors does not automatically mean you have insulin resistance. Instead, these factors help guide decisions about appropriate testing and follow-up.
Yes. Lifestyle changes can improve insulin sensitivity and help reduce the risk of developing type 2 diabetes.
Here are some practical steps you can take:
In some cases, a doctor may also recommend medication. However, you should never start treatment based on a fasting insulin or HOMA-IR result alone.
Insulin resistance can develop quietly, often before blood glucose levels become abnormal. Therefore, understanding your risk factors and choosing appropriate tests can help you and your doctor assess metabolic health more effectively.
Fasting blood glucose and HbA1c help assess blood sugar regulation, while fasting insulin and HOMA-IR may provide additional information in selected cases. A lipid profile and other clinical findings can also help build a more complete picture.
The right test depends on your individual health needs. Consult a qualified healthcare professional to determine which assessments are appropriate for you.
Jalaram Diagnostics, Bardoli, supports preventive health assessment through laboratory investigations that help clinicians evaluate glucose regulation and related metabolic risk factors. Depending on your health profile, your doctor may recommend tests such as fasting blood glucose, HbA1c, a lipid profile or selected additional investigations. The aim is to choose tests that answer a relevant clinical question—not to order every available marker. Discuss your results with your healthcare professional to understand their significance and decide on appropriate next steps.
Book your test / appointment now on +91 84 1980 1980
1. Can you have insulin resistance with normal blood sugar?
Yes. The body may compensate for reduced insulin sensitivity by producing more insulin, keeping glucose within the normal range for a period of time. A normal glucose result does not by itself confirm or exclude insulin resistance.
2. Is HOMA-IR a definitive insulin resistance test?
No. HOMA-IR is a surrogate measure, and its interpretation depends on the assay, population and clinical context. It should not be treated as a universal standalone diagnostic test.
3. Should everyone get fasting insulin tested?
No. Fasting insulin and HOMA-IR are not necessary for every person. A doctor can determine whether they add useful information beyond standard glucose and metabolic assessments.
